ABSTRACT
INTRODUCTION
Tuberous sclerosis complex (TSC) is a multisystem genetic disease with widespread manifestations including neuropsychiatric features such as intellectual disability (ID) [1, 2] . It is an autosomal dominant disorder caused by mutations in the TSC1 [3] or TSC2 [4] genes. Roles attributed to TSC1 include stabilisation and correct localisation of TSC2 [5, 6] . The TSC1-TSC2-TBC1D7 complex [7] [8] [9] modulates multiple intracellular processes, notably through TSC2's GTPase activating protein (GAP) domain [10] . The GAP activity of TSC2 counteracts stimulation by RAShomologue enriched in brain (Rheb) of mammalian (or mechanistic) target of rapamycin complex 1 (mTORC1), which phosphorylates proteins including p70 S6 kinase (S6K1) [9, 11] . TSC1 and TSC2 receive many inputs with activating or inhibitory effects on signalling [1] , and loss of TSC1/TSC2 disturbs downstream signalling.
Intellectual disability (ID) is defined as an Intelligence Quotient (IQ) below 2 standard deviations of the mean (IQ/DQ <70), and associated functional impairment in daily life [12] . Although prevalence of ID in the general population is approximately 2.2%, epidemiological analysis of TSC in south-west England showed ID prevalence in TSC of 44.4% [13] . The pattern of ID was not a typical unimodal Gaussian distribution, but bimodal, with 70% of individuals on a normal distribution shifted slightly down (mean (µ) = 93.6, standard deviation (σ) =13.8) and 30% with 'profound' intellectual disability (µ < 20) [13, 14] .
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Until discovery of the roles of the TSC1-TSC2-TBC1D7 complex, it was assumed that the predominant causal contributions to intellectual and neurocognitive manifestations of TSC were from structural abnormalities (cortical tubers), seizure phenomena (epilepsy) or interaction between the two [15, 16] . However, de Vries and Howe suggested that seizures and tubers were neither necessary nor sufficient to explain the neuropsychiatric variability of TSC [17] . For example, less than 50% of IQ variance was explained by seizure and tuber factors in the study by O'Callaghan et al [16] . Instead de Vries and Howe proposed TSC-associated neuropsychiatric disorders to be direct molecular consequences of disturbance of cell signalling/development [17 and refs therein] . Supporting this, animal models show a direct route from mutation to disruption of neurocognitive functions through mTOR overactivation [17] [18] [19] . There is also evidence for reversal of neurocognitive manifestations by mTOR inhibitors in animal models [19, 20] and possibly in humans [21] .
Consequences of mutations in TSC2 are typically more severe than for TSC1 [22] [23] [24] [25] [26] [27] .
De Vries and Howe proposed that, given that not all mutations were necessarily null, different mutations within TSC1 or TSC2 would have different consequences according to biochemical effects on the proteins [17] . This raised the possibility of using the nature of a given mutation to predict intellectual ability in TSC individuals, which could be scientifically and clinically valuable.
To date only three studies of genotype-phenotype associations in TSC utilised validated and standardised measures of intellectual ability/developmental level [24, 27, 28] . Lewis et al. [24] measured IQ of 92 individuals with TSC and known Page 6 of 30 mutations, performing a categorical genotype-phenotype analysis, dividing subjects into 'impaired' and 'non-impaired' based on IQ score below or above 70. They suggested TSC2 mutations were more likely to be associated with ID than TSC1 mutations. Jansen and colleagues performed comprehensive neuropsychological assessment of 59 TSC subjects [27] . The battery included measures of IQ, memory, attentional and executive skills and motor reaction times, and a 'cognition index' was calculated by summing scaled scores across neuropsychological domains. They concluded that TSC1 and TSC2 'groups overlapped almost completely' and prediction of cognitive phenotype should not be based on whether an individual had a TSC1 or TSC2 mutation.
In the most recent genotype-phenotype study of IQ in TSC, van Eeghen et al.
examined 137 subjects from a clinical case series [28] , utilizing a range of standardised IQ/DQ measures. Rates of ID were 23% in those with TSC1 and 59% in those with TSC2 mutations, and several inter-mutational correlations were observed, some contrasting with earlier findings.
These studies had methodological weaknesses, particularly in the psychometric approach to IQ/DQ data. Intelligence is not a categorical phenomenon, being normally distributed across a population with µ =100 and σ = 15. Given that IQ/DQ distribution in TSC is bimodal, de Vries and Prather suggested that individuals in the profoundly impaired range (IQ<20) and those in the normal distribution be considered as separate cognitive phenotypes, perhaps representing different underlying mechanisms [14] . Statistically, it is inappropriate to perform parametric analysis with the TSC distribution pattern. Earlier studies [24, 28] did not examine the actual shape Page 7 of 30 of IQ distribution across TSC1 and TSC2, represented by mean and standard deviation data. TSC2 may, for instance, have been reported as more severe than TSC1 because most individuals with profound ID had a TSC2 mutation. There are two main criticisms of the study by Jansen et al. [27] . In spite of the comprehensive neuropsychological battery, scores were collapsed into 4 categories. Given that a score of 1 represented performance < 70, more than 50% of the study data would have been in this category, preventing separation of mild, moderate, severe and profound intellectual disability. Secondly, Jansen's 'cognition index' is of unknown biological meaning, since neurobiological substrates of skills such as memory, attention, executive skills and motor function are highly different, and mutational or molecular correlates may be domain specific.
In van Eeghen et al's study only 44% of the clinic series had neuropsychological evaluations, possibly skewing the sample towards milder phenotypes as shown by the low proportion with profound ID [28] . No mean and standard deviation data were presented, limiting interpretation of the 'shape' of IQ/DQ distributions. Also the study did not consider familial/sporadic status (the latter being associated with a more severe phenotype [22] ) resulting in a possible ascertainment bias.
Given the earlier proposal that different mutation types have different effects [17] , we tested if different kinds of TSC1 or TSC2 mutations correlated with effects on IQ/DQ.
We were interested in predicted effects of mutations on levels of mutant proteins through nonsense-mediated decay (NMD) or protein degradation (PD). NMD is a degradation-mediated reduction in levels of transcripts carrying premature termination codons (PTC), occurring if the PTC is shortly before the last exon-exon junction [29] .
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NMD has been demonstrated for TSC1 but was shown to be incomplete in RNA isolated from blood, and from lymphoid and fibroblast cell lines [30] , raising the possibility that mutant protein might be present in individuals with TSC1 or TSC2 mutations. We therefore tested for association between the predicted nature of any residual mutant protein and phenotype. PD is known to cause significant reduction in levels of TSC1 with mutations close to the N terminus [31] [32] [33] .
We examined the association between genotype and intellectual phenotype, extending and reanalysing the sample used by Lewis et al. [24] , and interpret the results in terms of a model for stability and effects of mutant proteins.
METHODS

Subjects
Ninety-two unrelated subjects were recruited and assessed as described previously (the 'Cardiff' study) [24] . An additional 21 unrelated subjects were volunteers from the Tuberous Sclerosis Association, UK, recruited for a separate ('Cambridge') study [34] . After confirmation of clinical criteria for TSC [35] , subjects consented for their information to be used for research. Protocols received ethical approval. Only subjects with complete psychological and genetic profiles were included, excluding individuals with no mutation identified, no IQ/DQ score, or undetermined TSC1/TSC2 status.
IQ/DQ assessments
In the Cardiff study, JCL assessed IQ using Wechsler Adult Intelligence Scale Revised (WAIS-R) [ [38] or the Vineland Adaptive Behaviour Scale (VABS) [39] . WAIS-R and WISC-III are standard measures of IQ suitable for individuals able to participate in direct testing. The floor of IQ measurement using these tools is ~ 45. Although WAIS-R and WISC-III are more reliable, they are unsuitable to determine IQs in individuals with lower abilities. In these cases the RCPM or VABS may be useful. RCPM is recognised as a measure of 'fluid intelligence' whereas VABS is an indirect measure of adaptive behaviours in daily life, used to estimate a developmental quotient (DQ) as proxy for IQ. In the Cambridge study, DLM used the Wechsler Abbreviated Scale of Intelligence (WASI), WISC-III or WAIS-R [40] to calculate full-scale IQ. Given the challenges of measurement across age and ability, we calculated a 'best estimate IQ/DQ' using a hierarchical approach (WAIS-R/WISC-III > WASI > RCPM > VABS). As per ICD-10 convention, ID was defined as IQ/DQ < 70 and profound ID as IQ/DQ < 20 [41] .
Mutation detection and categorisation
Mutations were analysed by screening coding sequences and intronic splice site regions of TSC1 and TSC2, using single strand conformation polymorphism analysis, denaturing high performance liquid chromatography, high resolution melt analysis and Sanger sequencing, and assessing both loci for large rearrangements using multiplex probe ligation analysis [42, 43] . Mutations were categorised as missense, Page 10 of 30 nonsense, frameshift, in-frame deletions, large deletions, splice-site mutations and undetermined. Missense mutations were classified as non-conservative if they resulted in substitution between biochemical groups as defined by Clustal X [44] . Regions of TSC1 and TSC2 considered in mutation mapping are shown in Supplementary Figure   1 . NMD was predicted if the PTC either generated directly by mutation, or resulting from a frameshift, was >18 codons upstream of the last exon-exon junction [29] .
Junctions were as in the Leiden Open Variation Database (LOVD) TSC1 and TSC2 reference sequences [45] . Splice-site mutations, splice variants and possible effects on splicing of mutations away from splice sites were not considered, given the lack of detailed information on splicing. For frameshifts, the position of the next termination codon and the length of the 'aberrant tail' between it and the mutation site were determined using the LOVD sequences. To predict mutation distributions we assumed that each codon in TSC1 and TSC2 was equally likely to mutate to a PTC. we carried out additional calculations using the reference sequence to estimate the actual number of positions at which a single insertion, deletion or substitution could lead to escape from NMD. We assumed insertions and deletions were equally likely, and calculated under models in which (i) only transitions occurred or (ii) transitions and transversions were equally likely. For TSC1 truncating mutations, PD was predicted to occur if the PTC was within the first 350 codons [32] , although it is recognized that some non-pathogenic mutations in this region may not affect the Page 11 of 30 structure [46] and some mutations outside this region may destabilise the protein. truncating mutations, the GAP status was assumed to depend on whether the domain was fully intact (present) or truncated (absent).
Statistical Analysis
Data analysis was performed using SPSS version 21. Differences in IQ/DQ scores were analysed using the non-parametric Mann-Whitney U test. The KolmogorovSmirnov test was used to assess normality of IQ/DQ distributions above 19. 2x2 contingency tables were assessed using Fisher's exact test. Spearman's rank correlation test was used to correlate two independent variables. A threshold of p<0.05 was considered statistically significant in all tests and no corrections were made for multiple testing.
RESULTS
Subject characteristics
Of the 113 participants (92 from the Cardiff study [24] and 21 from the Cambridge study [34] ), 13 were excluded because intellectual or genetic data were incomplete.
Of the remaining 100 subjects, 26 had TSC1 and 74 TSC2 mutations. There were 47 males and 53 females, 82 sporadic and 15 familial cases, with 3 of undetermined familial/sporadic origin. Details of mutations are given in Supplementary Table 1 . Figure 2) were stratified and compared to the expected distribution in the general population (Table 1) . Proportions with profound impairment were 28%, 11% and 34% (all, TSC1 and TSC2 respectively). Excluding subjects with profound ID, Kolmogorov-Smirnov tests showed normal distributions for remaining IQ scores (All p = 0.574; TSC1 p = 0.915; TSC2 p = 0.551). TSC2 was associated with significantly lower IQ/DQ than TSC1 (Table 2) 
IQ/DQ in TSC1 and TSC2
IQ/DQ scores (Supplementary
Mutation Characteristics for TSC1 -NMD, Protein Degradation and TSC2
interaction TSC1 frameshift mutations (Table 3 and Supplementary Fig 3A) were associated with significantly lower IQ/DQ than nonsense mutations (difference between mean IQ/DQ = 34.9; Z = -2.233; p=0.026). No TSC1 missense mutations were found. All 25 TSC1 truncating (i.e. nonsense or frameshift) mutations were predicted to result in NMD. were also predicted to result in NMD, which was statistically highly significant compared to the null hypothesis that they were evenly distributed throughout the gene (p<0.0001, Table 4 ). Predictions based on the more detailed calculation of sites where a single mutation could result in escape from NMD gave similar conclusions (not shown). 
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The numbers of TSC1 mutations predicted to cause truncation in the region leading to protein degradation ('PD mutations') rather than the non-PD region ('no-PD mutations') in our dataset and the LOVD database were not significantly different from expectation. However, mutations predicted to result in PD were associated with higher IQ/DQ than non-PD mutations (Table 5 ). When only sporadic cases were considered, to reduce ascertainment bias, the difference was even more marked and significant (mean difference in IQ/DQ = 45.8; Z = 2.275; p=0.027). HoogeveenWesterveld et al. reported that substitutions in the first 224 amino acids could lead to protein instability [33] . Mutations in our dataset causing truncations within this more restricted region were also associated with a higher IQ/DQ than mutations leading to distal truncations, but sample numbers were too small for statistical analysis.
Individuals with mutations within the tuberin-interaction domain (TID) of TSC1
showed higher mean IQ/DQ (n=6, µ=101.3, σ= 13.6) than others (n=19, µ=83.3, σ= 34.6) and higher mean than those with mutations elsewhere in the first half of the protein (n=7, µ=90.4, σ= 16.9). The differences were not significant, although this may reflect small sample sizes. 
Correlation of predicted length of aberrant tail in TSC1 and IQ/DQ
We tested for a correlation between the predicted lengths of aberrant tails generated by the frameshift or nonsense mutations and IQ/DQ ( Figure 1A and Supplementary Table 3 ). Mutant proteins (frameshift or nonsense, 15 individuals) not predicted to be subject to PD showed significant negative correlation between tail length and IQ/DQ (rho = -0.706; p = 0.003).
Mutation Characteristics for TSC2 -NMD, TSC1 interaction and GAP status
Unlike TSC1, there were several missense TSC2 mutations (supplementary Fig 3B) . [28] . In our study there was only one participant with a missense mutation in exons 22-33, with IQ/DQ=19. Of the 12 with missense mutations elsewhere, five also had IQ/DQ <20. Missense mutations were associated with lower IQ/DQ than truncating mutations, but the difference was not significant (n=13, µ=37.8, σ= 29.8 and n=30, µ=52.9, σ= 31.8 respectively, p=0.224). Among truncating mutations, there was no significant difference between frameshift and nonsense mutations (Table 3 ). In-frame deletions were associated with a higher IQ/DQ (n=4, µ=71.0, σ= 16.8) than truncations, but the sample was too small for statistical testing. There were 9 splice site mutations (µ=68.6, σ= 29.8), and 18 large deletions (µ=55.8, σ= 39.5).
For TSC2 PTC mutations the numbers of NMD and no-NMD mutations were not significantly different from expected, either in our dataset or in the LOVD database (Table 4) . No-NMD mutations were associated with a lower IQ/DQ than NMD mutations (n = 3; µ= 31; σ 20.8; n = 27; µ = 55.4; σ= 32.2), although results were not statistically significant (Table 5 ).
There was one individual with a missense mutation in the TSC1-interaction domain of TSC2, defined as extending to the end of exon 11 [47] , with IQ/DQ =21. When the region considered was extended (HID, dotted line in Supplementary Figure 1 
DISCUSSION
IQ/DQ distribution
The IQ/DQ of our patients (Supplementary Figure 2) was comparable to those in another epidemiological study in the UK from 2003 [13] . Both studies showed bimodal IQ distribution, with similar proportions of ID and profound impairment (49.0% vs 44.4% and 28.0% vs 30.5% respectively), and suggesting our sample was representative of the TSC population at the time patient phenotypes were assessed.
Even excluding individuals with profound ID, the TSC1 and TSC2 'normal distribution' phenotypes [14] remained psychometrically and statistically significantly different, with TSC1 individuals psychometrically very similar to the general population, and TSC2 individuals associated with significantly lower IQ ( Table 2 ).
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Results confirmed that the higher proportion of ID in TSC2 was not simply attributable to more individuals with profound ID.
The lack of significant difference between males and females in mean IQ (Supplementary Table 2 ) or the proportion of ID (males 51.1% vs females 47.1%) or profound ID (males 27.7% vs females 28.3%) refutes earlier, non-standardised reports suggesting more ID in males with TSC [25, 26] , and replicates the observations made by van Eeghen et al. [28] .
Mutation characteristics for TSC1
The lack of TSC1 missense mutations in our sample of 26 individuals is consistent with previous reports that such mutations are rare [48] . It was remarkable that all 25 TSC1 truncating mutations in our sample and all 588 TSC1 truncating mutations in the LOVD database were predicted to show NMD. There are two possible interpretations.
Truncation of the TSC1 protein within the C-terminal 190 residues may have such a slight effect that mutations do not cause TSC, and are not seen in a sample of individuals chosen because they have the disorder. Alternatively, TSC1 proteins truncated within the C-terminal 190 residues may be lethal if present at wild-type levels, because of a dominant effect. We favour the latter explanation, for two reasons. [49] ) and a region involved in interaction with TSC2 [32] . Although the suggestion that truncating mutants of TSC1 not subject to NMD are embryonic-lethal because of dominant effects contrasts with the general view that TSC1 mutations have a mild phenotype, it is consistent with the demonstration [31] that TSC1 protein with substitutions at positions 50 or 117 can have a dominant negative effect, and the suggestion by these authors that protein with mutations elsewhere might also have a dominant negative effect [31] .
A deleterious effect of mutant TSC1 would also explain our observation that individuals with mutations predicted to result in PD showed higher IQ/DQ than those with mutations outside the PD region. Because NMD does not lead to complete loss of transcripts [30] , production of some truncated protein would be expected. We propose that this is not immediately degraded, but that lower levels persist for protein truncated within the PD region, resulting in less marked effects on IQ/DQ. In fact, these individuals showed a mean and standard deviation in IQ/DQ scores essentially identical to the general population. Furthermore, although no patients in this study had deletions of the entire TSC1 gene, we have observed 13 patients with such deletions in a larger diagnostic series and none was reported to have ID. Given the location of the TSC2-interaction domain towards the N terminus of TSC1, it is not surprising that individuals with mutations in the interaction domain also showed higher IQ/DQ than others (although this contrasts with the observation of van Eeghen et al).
Length of aberrant tail on TSC1
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For individuals with frameshift TSC1 mutations outside the PD region, effects on IQ/DQ were greater the longer the aberrant C-terminal tail on the predicted mutant protein, and frameshift mutations were associated with lower IQ than nonsense mutations. This could be explained if the aberrant tail increases the deleterious biochemical effects of the protein (or reduces its rate of degradation), again consistent with the notion that mutant protein is detrimental.
Mutation characteristics for TSC2
Results for TSC2 were quite different from those for TSC1, with no significant clustering of mutations in the NMD region in our population or in the TSC2 LOVD (Table 4) . Although truncating mutations predicted to give rise to NMD were associated with a higher IQ/DQ than no-NMD mutations, this was not statistically significant (Table 5 ). These observations suggest that mutant TSC2 proteins truncated near the C-terminus are only slightly deleterious in terms of IQ/DQ. The calmodulinbinding domain, the oestrogen receptor alpha binding site and a target site for the ribosomal protein S6 kinase are all within the no-NMD region [47] , although the functional relevance of these domains has not yet been fully established.
Van Eeghen et al. [28] reported that individuals with missense mutations in TSC2 had a higher IQ/DQ than those with premature truncation mutations, whereas we observed a tendency for the reverse. This may reflect the smaller sample size in our study. 
Length of aberrant tail on TSC2
In individuals with frameshift mutations, there was a positive but not statistically significant correlation between the length of the aberrant tail and IQ ( Figure 1B ). This might be explained if longer aberrant tails led to more effective clearing of mutant protein (for which degradation systems have been described [50] ) or reduced the deleterious effects of mutant protein.
Model for the effects of mutations
We propose the following model for the different effects of mutant TSC1 and TSC2 with our proposal that more rapid clearance of mutant protein in those individuals, leaves them relatively mildly affected [32] . The destabilizing effect of mutations close to the N-terminus of TSC1 is consistent with the existence of a conserved, tightlyfolded domain in this region [46] .
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We suggest that levels of truncated TSC2 protein are also reduced through NMD, with mutations in the no-NMD region leading to more severe, but not lethal, consequences. Mutant protein is degraded more effectively than TSC1, and proteins destabilized by having a long aberrant C-terminal tail are less deleterious.
However, it will be important to test biochemically the predictions of the model for levels and function of mutant TSC1 and TSC2 proteins. If the predictions are correct, it will also be important to understand why longer aberrant C-terminal tails have different effects on TSC1 and TSC2.
Our analysis solely considered genotypes, and other factors will also affect outcomes, illustrated by some individuals with the same mutation having very different IQ/DQ (e.g. TSC2 mutations R751X: IQ/DQ 19, 85, 94; Q1192X: IQ/DQ 19, 79 and R1459X: IQ/DQ 19, 19, 68). These factors include somatic mosaicism [51] , modifier genes (perhaps affecting NMD efficiency) [52] and environmental effects such as seizures [28] (although tubers and seizures combined accounted for only 47% of the variance in IQ in the study of O'Callaghan et al [16] ). Nevertheless, it is clear that there are differing effects of distinct mutations in TSC1 and TSC2 (and specific mutations associated with a mild phenotype have been recognized for some time, e.g., [53] ). , Larger-scale exploration of the relationship between the molecular consequences of TSC mutations, including direct measurements of levels and function of mutant proteins in vivo, and intellectual phenotype is required to confirm our findings and may lead to discoveries of direct relevance in the clinical setting. Correlations between IQ/DQ and the length of predicted aberrant C-terminal tail of nonsense and frameshift mutations. A) TSC1 mutations with and without predicted protein degradation, B) TSC2 mutations not predicted to be subject to NMD. For both panels the y-axis indicates IQ/DQ and the x-axis length of the predicted aberrant C-terminal tail arising from frameshift mutations (0 for nonsense mutations). For TSC1 cases where mutant protein was not expected to be degraded, there was a strong negative correlation between the length of the C-terminal aberrant tail and IQ/DQ (rho = -0.706; p = 0.003). 
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